Accenture Song boosts life sciences portfolio with ConcentricLife takeover

Accenture (NYSE: ACN) has finalized the purchase of ConcentricLife, a prominent healthcare marketing agency known for assisting Life Sciences brands in optimizing brand experiences. This strategic move is part of Accenture Song’s commitment to enhancing its end-to-end solutions, focusing on engaging communications and experiences tailored to the dynamic health journeys of modern patients and healthcare professionals.

ConcentricLife Joins Accenture Song

Following the initial announcement on October 25, 2023, ConcentricLife—a subsidiary of Stagwell (NASDAQ: STGW)—joins Accenture Song with a team of over 270 professionals. This team brings a wealth of knowledge in the realms of rare diseases, healthcare, and wellness, backed by robust marketing capabilities that span the organization.

Accenture Expands Healthcare Marketing Expertise with ConcentricLife Acquisition. Photo courtesy of Roberto Fiadone/Wikimedia Commons.

Strengthening Life Sciences Capabilities

ConcentricLife, founded in 2002 and recognized as one of the MM+M Agency 100, has been lauded as a top agency in the health sector. Its global, award-winning work with influential biopharma companies solidifies its status in the industry. With this acquisition, Accenture Song is poised to further enhance its healthcare marketing and communications offerings, ensuring life sciences clients can achieve growth and transform the health and wellness experiences of today.